Google's UK AI Opt-Out Mandate: A Step Toward Fairer Digital Ecosystems

AI in Medicare Prior Authorization: A Step Too Far

The introduction of artificial intelligence (AI) into Medicare's prior authorization process through the Wasteful and Inappropriate Service Reduction (WISeR) pilot program raises significant concerns about patient care and access to necessary treatments. While the goal of reducing waste and fraud in healthcare spending is commendable, the reliance on AI for determining medical necessity introduces potential risks that could harm vulnerable patients. The WISeR program, launched in January 2024, affects six states-New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington-and targets over a dozen medical procedures, including epidural steroid injections and nerve-stimulation therapies. However, early reports indicate that the AI-driven system is causing delays of up to three weeks for prior authorization decisions, compared to the previous 24 to 72-hour turnaround time. This delay forces patients to reschedule treatments multiple times, allowing their conditions to worsen and increasing unnecessary suffering. Moreover, the lack of transparency in AI decision-making further exacerbates these issues. Patients and healthcare providers are left in the dark when denials occur, often without a clear explanation from human reviewers. U.S. Senator Maria Cantwell has called for immediate action, urging CMS to ensure that all denials include written explanations from humans rather than relying solely on AI-generated decisions. The absence of such transparency undermines trust between patients and their medical teams, who are already strained by the complexities of healthcare delivery. Critics argue that the WISeR program's structure incentivizes third-party contractors to maximize profitability by denying claims, rather than focusing on patient outcomes. This profit motive creates a conflict of interest, as companies stand to gain financially from reducing payouts. Iris Smith, an 80-year-old Medicare beneficiary in Florida, expresses concern that AI could become a barrier between patients and the care they need. "My doctors know me," she says. "When I'm in pain, I need something to take care of it." The human element is irreplaceable in healthcare, and replacing it with an algorithm risks overlooking individual circumstances that require personalized attention. Looking forward, the future of AI in Medicare must balance efficiency with patient-centered care. While AI has potential applications in streamlining administrative tasks and detecting fraud, its role in making decisions about medical necessity should be carefully scrutinized. Policymakers must ensure that any expansion of AI-driven prior authorization is accompanied by robust safeguards to protect patients' access to necessary treatments. In conclusion, the WISeR program's reliance on AI for prior authorization represents a step too far in the pursuit of cost savings. The delays, lack of transparency, and potential profit motive create significant risks for patient care. Moving forward, CMS must prioritize patient outcomes over cost-cutting measures, ensuring that healthcare decisions remain in the hands of trained medical professionals rather than algorithms.

The Essential Role of AI Inventories in Governing EU's AI Act Compliance

The European Union's AI Act is set to revolutionize how organizations manage artificial intelligence systems. As businesses rush to comply with this stringent regulation, one crucial tool stands out as indispensable: the AI inventory. This article argues that maintaining a robust AI inventory is not just a legal formality but a strategic necessity for effective governance and compliance under the EU's AI Act. An AI inventory goes beyond listing tools like chatbots or analytics platforms-it maps every AI system to its business purpose, data inputs, outputs, and human oversight points. Many organizations currently underestimate their AI estate, often discovering it is far more extensive than anticipated. This lack of visibility creates a significant barrier to compliance. By contrast, a detailed inventory provides clarity, enabling businesses to identify which systems fall under the Act's scope and prioritize resources accordingly. Consider this: An EU-wide survey revealed that 70% of organizations struggle to locate all their AI systems. Without an accurate inventory, companies cannot effectively classify risks, assign ownership, or track compliance status. The minimum viable AI inventory requires capturing critical details like business owner, technical lead, vendor information, input data categories, and output uses. For instance, if a hiring chatbot influences employment decisions, the inventory must flag this for human review and transparency requirements. The AI inventory also serves as a dynamic governance tool. It ensures accountability by designating an "evidence owner" for each system-the person responsible for requesting documentation or retaining records. This prevents the inventory from becoming a static list and integrates it into daily operations. For example, if a fraud detection model needs vendor evidence, the designated owner ensures this information is retrieved and verified. Looking ahead, the EU AI Act will require continuous updates to inventories as new AI features are added or existing systems evolve. Traditional annual reviews won't suffice; inventories must be living documents that reflect real-time changes in the AI landscape. By embedding the inventory into governance processes, organizations can build a foundation for long-term compliance and trust. In conclusion, the AI inventory is more than a checkbox exercise-it's the cornerstone of effective AI governance under the EU's AI Act. It empowers businesses to understand their AI estate, meet regulatory obligations, and foster transparency. As the deadline for compliance approaches, organizations that prioritize building and maintaining a comprehensive AI inventory will be better positioned to navigate this new era of AI regulation with confidence.

The Hidden Cost of AI in Medicare: Seniors Suffer While Bureaucrats Look Away

The roll-out of the Wasteful and Inappropriate Service Reduction (WISeR) program, a federal pilot using artificial intelligence to review Medicare treatment approvals, has created a quiet crisis for seniors. Instead of streamlining care, AI is being used as a tool to delay or deny necessary medical procedures, leaving vulnerable patients in excruciating pain. This editorial dives into the real-world consequences of this misguided policy and argues that AI should never be allowed to override doctors’ judgment when it comes to patient care. The WISeR program, launched in January 2024, affects six states, including Washington, where Senator Maria Cantwell has been a vocal critic. The system requires prior authorization for certain treatments through private contractors using AI technology. This shift has led to alarming delays: some patients now wait up to eight weeks for approvals, compared to just two weeks before the program started. For seniors like Michael Edgerly, who suffers from degenerative disc disease and scoliosis, this means months of unnecessary pain and limited mobility. His doctor recommended an epidural steroid injection-a common and effective treatment-but WISeR denied the request outright. The problem isn’t just about delays; it’s about AI making decisions that should be left to medical professionals. The program’s contractors are incentivized to deny claims based on “averted expenditures,” creating a financial motive to say no rather than focus on patient needs. Hospitals and doctors across Washington report that denials often lack clear explanations or contradict clinical standards. This isn’t modernization-it’s a bureaucratic nightmare. Senator Patty Murray has called for an end to this harmful experiment, introducing the Seniors Deserve SMARTER Care Act to halt the WISeR model. Cantwell and Murray argue that AI should never replace the judgment of healthcare providers, especially when it comes to life-saving treatments. Their resolution, introduced under the Congressional Review Act, aims to block the program entirely. If passed, it would send a clear message: seniors’ health shouldn’t be at the mercy of algorithms designed to cut costs. The stakes are high. Medicare is supposed to provide accessible, reliable care for our nation’s seniors. Introducing AI into this system has only added layers of complexity and inefficiency. Patients like Edgerly aren’t asking for experimental solutions-they need timely, effective treatment. The federal government should focus on policies that prioritize people over profits, not the other way around. As lawmakers continue to debate the future of Medicare, one thing is clear: AI is no substitute for compassion and medical expertise. Seniors deserve better than a system that uses technology to deny care. It’s time to reject this flawed model and build a healthcare system that truly puts patients first.

What Nobody Is Saying About Connecticut AI in Employment Decisions

Connecticut's emerging approach to regulating AI in employment decisions is a microcosm of the broader tension between innovation and control. While states like Colorado and Illinois are leading the charge with new laws, Connecticut is lagging behind, leaving employers and employees in limbo. The push for AI regulation stems from legitimate concerns about bias and fairness. In Colorado, lawmakers initially tried to create a comprehensive framework but quickly realized it was too ambitious. The state's revised law now focuses on transparency rather than strict governance, requiring companies to notify job applicants when AI is used in hiring decisions. This shift reflects a growing recognition that overly restrictive regulations can stifle innovation without delivering clear benefits. In contrast, Connecticut has yet to pass any significant AI-related employment laws. This inaction is problematic. As other states set precedents, employers in Connecticut face uncertainty. Should they follow federal guidelines or try to comply with varying state laws? The lack of clarity creates a competitive disadvantage, as businesses may hesitate to adopt AI tools without clear legal parameters. Looking ahead, the stakes are high for both employers and employees. If Connecticut continues to lag, it risks losing talent and business to more proactive states. At the same time, overregulation could stifle the very innovations that could boost efficiency and fairness in hiring. Connecticut needs a balanced approach-one that prioritizes transparency without stifling innovation. By learning from other states' experiences, the state can craft regulations that protect workers while allowing employers to thrive in the AI era. The future of work in Connecticut depends on getting this balance right.

The EU AI Act's Grand Challenge: Governing Without the Means to Implement

The European Union's AI Act represents a monumental leap in regulatory ambition. Yet, as its implementation deadline looms, a stark reality emerges: the EU itself may not be fully prepared. While the legislation sets a global benchmark for AI governance, many member states are struggling to establish the necessary infrastructure and expertise to enforce it. For instance, by May 2026, only eight of the 27 EU nations had designated single points of contact, underscoring a significant gap in readiness. The delay highlights a critical dilemma: crafting comprehensive regulations is one thing, but executing them effectively requires robust institutional capacity. In contrast, smaller jurisdictions like the Cayman Islands are navigating this challenge by integrating AI governance into existing regulatory frameworks. By leveraging their financial services regulator and ombudsman, they're demonstrating that regulation doesn't need to be built from scratch-it can evolve within existing structures. This approach emphasizes the importance of adaptive strategies over rigid models. The EU's predicament isn't unique. The UN reports that 118 countries, predominantly in the Global South, remain absent from major AI governance initiatives, leaving them at a disadvantage. These nations lack both the regulatory machinery and resource capacity to implement complex frameworks like the EU AI Act. The situation raises profound questions about the feasibility of exporting such models to regions with limited institutional resources. The Cayman Islands' experience offers valuable insights-they've prioritized AI literacy and education before jumping into regulation, believing that true protection stems from understanding rather than mere rule-making. As the EU struggles with implementation delays, it's worth considering whether their regulatory framework is truly scalable. Smaller jurisdictions are proving that governance can be adaptive, not just replicable. The challenge for the EU-and the world-is to recognize that AI regulation isn't one-size-fits-all. It requires tailored approaches and a focus on building capacity rather than just setting standards. In the end, the EU AI Act's success hinges not just on its policies but on the ability of nations to execute them effectively. As deadlines approach and resources stretch thin, the real test lies in whether regulators can adapt their strategies to match the scale of their challenges.